Home > Healthcare > Medical Devices > Implantable Devices > Vascular Graft Market

Vascular Graft Market Size

Report ID: GMI2492
Published Date: Dec 2024
Report Format: PDF

Download Free Sample

Vascular Graft Market Size

The global vascular graft market size was valued at USD 3.6 billion in 2024 and is expected to exhibit growth at a CAGR of 6.9% from 2025 to 2034 period. The market growth is attributed to the increasing prevalence of cardiovascular diseases, technological advancements, rising incidence of end-stage renal disease (ESRD), and increase in surgical procedures, among other contributing factors.

To get key market trends

Download Free Sample

Moreover, the increasing prevalence of cardiovascular diseases, such as atherosclerosis and coronary artery disease, drives the demand for vascular grafts. For instance, according to the World Health Organization (WHO), cardiovascular diseases cause around 17.9 million deaths annually, accounting for 32% of global deaths. These medical conditions frequently require bypass grafting and other surgical procedures. The growing elderly population and lifestyle-related health factors contribute to the higher occurrence of cardiovascular diseases, expanding the need for vascular grafts.

Vascular Graft Market Report Attributes
Report Attribute	Details
Base Year:	2024
Vascular Graft Market Size in 2024:	USD 3.6 Billion
Forecast Period:	2025 - 2034
Forecast Period 2025 - 2034 CAGR:	6.9%
2034 Value Projection:	USD 7.3 Billion
Historical Data for:	2021 - 2024
No. of Pages:	140
Tables, Charts & Figures:	136
Segments covered:	Raw Material, Application, End Use, Region
Growth Drivers:	Increasing number of chronic diseases worldwide Growing number of end-stage renal disorders in developing economies Technological advancements in developed countries Rise in organ transplantation
Pitfalls & Challenges:	Lack of skilled personnel in developing countries

Learn more about the key segments shaping this market

Download Free Sample

Furthermore, innovations such as bioengineered, hybrid, and synthetic vascular grafts have improved graft performance and patient outcomes. These advancements provide enhanced durability and biocompatibility. Additionally, the rise of minimally invasive procedures has made vascular surgeries safer and more accessible, boosting market growth.

Vascular graft is a medical device used to replace, repair, or bypass damaged blood vessels. It can be made from synthetic materials, biological tissues, or a combination of both, and is commonly used in procedures such as coronary artery bypass, intracranial aneurysm repair, and hemodialysis access. Vascular grafts help restore normal blood flow and prevent complications like ischemia or rupture.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global vascular graft industry was valued at USD 3.6 billion in 2024 and is projected to grow at a CAGR of 6.9% from 2025 to 2034, driven by the increasing prevalence of cardiovascular diseases and advancements in surgical technologies.

The polyester grafts segment is expected to grow at a CAGR of 7.3%, reaching over USD 4.7 billion by 2034, owing to its durability and resistance to degradation, making it ideal for vascular surgeries.

Polyester grafts, often made from materials like Dacron, are highly durable and can withstand high blood flow pressure, making them suitable for long-term use, particularly in large vessel repairs.

The U.S. vascular graft market was valued at USD 1.1 billion in 2024 and is anticipated to grow at a CAGR of 6.1% from 2025 to 2034, driven by the adoption of advanced surgical techniques like endovascular aneurysm repair (EVAR).

Key players in the vascular graft industry include Abbott, ARTIVION, B. Braun, BD (Becton, Dickinson & Company), Cook Medical, Cordis, Endologix, GETINGE, LeMaitre, Medtronic, and MERIT MEDICAL.